» Articles » PMID: 18195472

Characterization of an Antiproliferative Effect of Imidazoline Receptor Ligands on PC12 Cells

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2008 Jan 16
PMID 18195472
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed at investigating the influence of imidazoline receptor ligands on the proliferation of PC12 cells and the involvement of the sphingosine-1-phosphate (S1P) signaling system in this effect. In cultured PC12 cells, S1P (0.3-100 nM) and the I(1) imidazoline receptor ligands moxonidine (0.3 and 1 mM), agmatine (1 mM), idazoxan (10-100 microM) and efaroxan (1-100 microM) concentration-dependently reduced protein contents which were used as estimates for cell number. The antiproliferative effects elicited by the compounds were abolished after knock-down of S1P(1), S1P(2) and S1P(3) receptors by RNA interference indicating an involvement of S1P receptors. In conclusion, the present data add further evidence to the recent finding that effects of imidazoline receptor ligands in PC12 cells are mediated by homo- and heterodimers of members of the S1P receptor family.

Citing Articles

Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Bonisch H, Fink K, Malinowska B, Molderings G, Schlicker E Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(9):1829-1867.

PMID: 33991216 PMC: 8376721. DOI: 10.1007/s00210-021-02083-5.


Analysing the effect of I imidazoline receptor ligands on DSS-induced acute colitis in mice.

Feher A, Toth V, Al-Khrasani M, Balogh M, Lazar B, Helyes Z Inflammopharmacology. 2016; 25(1):107-118.

PMID: 27873165 DOI: 10.1007/s10787-016-0299-7.